Bridgeway Capital Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Bridgeway Capital Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-41,060	Closed	-$47K	–	1484
2017 Q3	$47K	Sell	41,060 -56,205	-58%	-$60.3K	﹤0.01%	1372
2017 Q2	$113K	Sell	97,265 -33,795	-26%	-$39.3K	﹤0.01%	1353
2017 Q1	$172K	Hold	131,060	–	–	﹤0.01%	1297
2016 Q4	$275K	Hold	131,060	–	–	﹤0.01%	1246
2016 Q3	$347K	Sell	131,060 -79,800	-38%	-$199K	0.01%	1202
2016 Q2	$401K	Buy	210,860 +75,000	+55%	+$197K	0.01%	1138
2016 Q1	$399K	Buy	135,860 +52,800	+64%	+$151K	0.01%	1132
2015 Q4	$259K	Hold	83,060	–	–	﹤0.01%	1245
2015 Q3	$262K	Buy	83,060 +20,000	+32%	+$77K	0.01%	1258
2015 Q2	$240K	Buy	63,060 +19,500	+45%	+$74.8K	﹤0.01%	1314
2015 Q1	$205K	Buy	43,560 +15,300	+54%	+$88.2K	﹤0.01%	1331
2014 Q4	$180K	Buy	+28,260	New	+$165K	﹤0.01%	1324

Bridgeway Capital Management's OCRX Position: Q4 2017 in Review

Bridgeway Capital Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 41,060 shares — an estimated $47K sold.

Bridgeway Capital Management first reported a position in OCRX in Q4 2014 and held it in 12 quarters. The position peaked at $401K in Q2 2016. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

Bridgeway Capital Management reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Bridgeway Capital Management sold 41,060 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $47K.
Bridgeway Capital Management first reported a position in Ocera Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
Bridgeway Capital Management's Ocera Therapeutics, Inc. position peaked at $401K in Q2 2016.
0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Bridgeway Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.